Page last updated: 2024-10-21

ethylisopropylamiloride and Carcinogenesis

ethylisopropylamiloride has been researched along with Carcinogenesis in 1 studies

ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.

Carcinogenesis: The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Filippakis, H1
Belaid, A1
Siroky, B1
Wu, C1
Alesi, N1
Hougard, T1
Nijmeh, J1
Lam, HC1
Henske, EP1

Other Studies

1 other study available for ethylisopropylamiloride and Carcinogenesis

ArticleYear
Vps34-mediated macropinocytosis in Tuberous Sclerosis Complex 2-deficient cells supports tumorigenesis.
    Scientific reports, 2018, 09-21, Volume: 8, Issue:1

    Topics: Amiloride; Animals; Autophagy; Autophagy-Related Protein 5; Carcinogenesis; Cell Line; Cell Prolifer

2018